Patients with high-risk aggressive lymphoma treated with frontline intensive chemotherapy and autografting: evidence of marked differences in outcome between patients with age-adjusted International Prognostic Index scores 2 and 3. [electronic resource]
Producer: 20030916Description: 983-92 p. digitalISSN:- 0008-543X
- Adult
- Age Factors
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Cyclophosphamide -- administration & dosage
- Cytarabine -- administration & dosage
- Etoposide -- administration & dosage
- Female
- Follow-Up Studies
- Humans
- Lymphoma, B-Cell -- drug therapy
- Lymphoma, Non-Hodgkin -- drug therapy
- Male
- Methotrexate -- administration & dosage
- Middle Aged
- Neoplasm Staging
- Peripheral Blood Stem Cell Transplantation
- Prognosis
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.